Fabrazyme helps people with Fabry disease by replacing a missing enzyme. It has been used to treat people with Fabry disease for over 15 years and is backed by the safety and effectiveness shown in clinical studies.HOW FABRAZYME CAN HELP YOU
Fabrazyme® (agalsidase beta) is used to treat patients with Fabry disease. Fabrazyme lowers the amount of a substance called globotriaosylceramide (GL-3), which builds up in cells lining the blood vessels of the kidney and certain other cells.
The lowering of GL-3 suggests that Fabrazyme may improve how Fabry disease affects your body; however a relationship of lower GL-3 to specific signs and symptoms of Fabry disease has not been proven.